Prescription Regulations And Safety Warnings - NAPLEX

No federal refill limit; follow prescriber authorization and state law. Schedule V drugs have low abuse potential, so federal law permits unlimited refills based on prescriber judgment and state restrictions.

All refills must be dispensed within $6$ months. The 6-month limit prevents indefinite refilling of Schedule III and IV prescriptions without prescriber reevaluation.

On or after the date specified by the prescriber. This rule allows prescribers to delay dispensing of Schedule II drugs until a specified future date for therapeutic reasons.

No federal maximum quantity; limited by legitimate medical purpose and state law. Federal law emphasizes medical legitimacy over quantity caps to accommodate varying patient needs while preventing diversion.

Schedule II only for LTCF patients, hospice, or parenteral narcotic for home infusion. Fax transmission is permitted as the original for Schedule II in these cases to expedite care in vulnerable patient populations.

It must be issued for a legitimate medical purpose in usual professional practice. The Controlled Substances Act mandates that prescriptions serve a valid medical need to prevent misuse and diversion.

Complete within $72$ hours; remainder is void after $72$ hours. The 72-hour rule for partial fills of Schedule II drugs balances drug availability with strict controls to reduce diversion risks.

May partial fill up to $60$ days from issue date with proper documentation. Extended partial filling for these patients accommodates their ongoing needs while maintaining documentation for oversight.

Schedule III–V: one-time transfer for remaining refills (unless real-time shared DB). Federal rules allow limited transfers of Schedule III-V refills to facilitate patient access without compromising tracking.

Transfers are not permitted; a new prescription is required. Prohibiting transfers of Schedule II prescriptions ensures tight control and prevents potential diversion between pharmacies.

iPLEDGE REMS requirements must be met prior to dispensing. iPLEDGE REMS enforces strict protocols to prevent fetal exposure due to isotretinoin's severe teratogenic risks.

Severe neutropenia risk; must comply with Clozapine REMS monitoring. Clozapine's boxed warning addresses agranulocytosis risk, requiring REMS to monitor absolute neutrophil counts regularly.

Provide the FDA Medication Guide with each dispensing. FDA mandates Medication Guides for high-risk drugs like warfarin to inform patients about bleeding risks and safe use.

Avoid alcohol during therapy and for at least $3$ days after the last dose. Metronidazole can cause a disulfiram-like reaction with alcohol, necessitating avoidance to prevent severe adverse effects.

Separate from antacids/iron/calcium by at least $2$ hours when possible. Doxycycline forms chelates with polyvalent cations, reducing absorption and efficacy if not separated appropriately.

Do not take with antacids/iron/zinc; separate dosing per product labeling. Fluoroquinolones bind to polyvalent cations, impairing bioavailability and requiring dosing separation to maintain therapeutic levels.

May cause drowsiness; avoid alcohol and use caution driving or operating machinery. Opioids cause central nervous system depression, increasing risks of impairment that warrant caution with sedatives and activities.

Do not exceed $4{,}000$ mg/day from all sources (lower if risk factors). Exceeding the daily acetaminophen limit risks hepatotoxicity, especially in patients with liver impairment or alcohol use.

Do not dispense; obtain a properly signed prescription per law and policy. A missing signature invalidates the controlled substance prescription under DEA regulations, requiring a valid signed original.

Do not refill; Schedule II prescriptions have no refills. Federal law strictly prohibits refills for Schedule II drugs to enforce close monitoring and prevent abuse.

Exceeds limit; maximum is $5$ refills within $6$ months. DEA regulations cap Schedule III refills at 5 within 6 months to limit total dispensings and ensure periodic reassessment.

Remainder is void; cannot dispense after $72$ hours (non-LTCF/non-terminal). The 72-hour limit for completing Schedule II partial fills prevents extended access and potential misuse in standard patients.

Do not dispense; patient must meet iPLEDGE timing requirements again. iPLEDGE enforces a strict dispensing window to verify pregnancy status and compliance, mitigating teratogenic risks.

Zero refills; a new prescription is required each time. Federal regulations prohibit refills for Schedule II substances to minimize abuse potential and ensure ongoing medical necessity.